GHP Investment Advisors Inc. Lowers Position in Teleflex Incorporated $TFX

GHP Investment Advisors Inc. trimmed its stake in Teleflex Incorporated (NYSE:TFX) by 6.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,478 shares of the medical technology company’s stock after selling 542 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Teleflex were worth $1,004,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. grew its holdings in Teleflex by 0.7% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company’s stock valued at $859,095,000 after purchasing an additional 43,642 shares during the period. Cooke & Bieler LP grew its holdings in Teleflex by 14.0% in the second quarter. Cooke & Bieler LP now owns 1,205,964 shares of the medical technology company’s stock valued at $142,738,000 after purchasing an additional 148,436 shares during the period. Dimensional Fund Advisors LP grew its holdings in Teleflex by 69.5% in the first quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock valued at $119,927,000 after purchasing an additional 355,720 shares during the period. Diamond Hill Capital Management Inc. grew its stake in Teleflex by 122.8% during the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company’s stock worth $80,784,000 after buying an additional 322,222 shares during the period. Finally, TD Asset Management Inc grew its stake in Teleflex by 0.7% during the first quarter. TD Asset Management Inc now owns 490,000 shares of the medical technology company’s stock worth $67,713,000 after buying an additional 3,310 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Zacks Research downgraded shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Royal Bank Of Canada boosted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a research note on Friday, August 1st. Weiss Ratings reiterated a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday, October 8th. Mizuho boosted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, August 1st. Finally, Wall Street Zen downgraded shares of Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. One investment analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $141.57.

Teleflex Price Performance

Shares of TFX stock opened at $122.66 on Tuesday. The company has a market capitalization of $5.42 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 1.79 and a beta of 1.05. The firm has a fifty day simple moving average of $126.51 and a 200-day simple moving average of $123.39. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a twelve month low of $108.90 and a twelve month high of $212.16.

Insider Buying and Selling at Teleflex

In other news, Director Gretchen R. Haggerty bought 500 shares of the firm’s stock in a transaction dated Wednesday, August 6th. The stock was acquired at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the purchase, the director owned 6,305 shares of the company’s stock, valued at $723,498.75. This trade represents a 8.61% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.40% of the company’s stock.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.